TABLE 3.
Ultrasonic follow‐up and CSD characteristics in 6 months
| Parameters | Units category | Experimental | Placebo | p | OR | 95% CI |
|---|---|---|---|---|---|---|
| Follow up ≥42,< 60 days | 50 | 55 | ||||
| Uterine length | 48.4 ± 6.4 | 47.6 ± 5.5 | 0.480 | |||
| Uterine width | 51.1 ± 6.6 | 50.9 ± 6.4 | 0.824 | |||
| Uterine thickness | 39.6 ± 6.4 | 39.7 ± 5.0 | 0.937 | |||
| CSD | Yes | 18 (36.0) | 26 (47.3) | 0.242 | 0.76 | 0.48–1.21 |
| No | 32 (64.0) | 29 (52.7) | ||||
| CSD width | mm | 10.6 ± 4.7 | 10.0 ± 5.9 | 0.740 | ||
| CSD length | mm | 7.4 ± 3.7 | 7.0 ± 4.1 | 0.750 | ||
| CSD depth | mm | 6.2 ± 3.3 | 6.4 ± 3.3 | 0.832 | ||
| RMT | mm | 6.3 ± 2.4 | 5.3 ± 3.1 | 0.266 | ||
| AMT | mm | 12.0 ± 2.7 | 11.4 ± 4.2 | 0.640 | ||
| Follow up ≥66 days | 54 | 53 | ||||
| Uterine length | 44.4 ± 4.8 | 45.7 ± 4.6 | 0.182 | |||
| Uterine width | 46.1 ± 5.5 | 47.6 ± 4.8 | 0.137 | |||
| Uterine thickness | 35.9 ± 6.0 | 38.8 ± 4.5 | 0.008 | |||
| CSD | Yes | 16 (29.6) | 24 (45.3) | 0.094 | 0.65 | 0.39–1.09 |
| No | 38 (70.4) | 29 (54.7) | ||||
| CSD width | mm | 9.8 ± 4.7 | 9.7 ± 4.3 | 0.984 | ||
| CSD length | mm | 6.9 ± 3.9 | 6.7 ± 3.4 | 0.893 | ||
| CSD depth | mm | 5.3 ± 2.7 | 7.0 ± 3.0 | 0.072 | ||
| RMT | mm | 4.6 ± 2.5 | 4.7 ± 3.2 | 0.885 | ||
| AMT | mm | 9.7 ± 2.5 | 10.9 ± 3.5 | 0.239 | ||
| Pooled data | 104 | 108 | ||||
| Uterine length | 46.4 ± 6.0 | 46.7 ± 5.1 | 0.688 | |||
| Uterine width | 48.5 ± 6.5 | 49.3 ± 5.9 | 0.382 | |||
| Uterine thickness | 37.7 ± 6.4 | 39.3 ± 4.8 | 0.053 | |||
| CSD | Yes | 34 (32.7) | 50 (46.3) | 0.043 | 0.71 | 0.50–0.99 |
| No | 70 (67.3) | 58 (53.7) | ||||
| CSD width | mm | 10.18 ± 4.63 | 9.87 ± 5.15 | 0.284 | ||
| CSD length | mm | 7.14 ± 3.71 | 6.86 ± 3.74 | 0.734 | ||
| CSD depth | mm | 10.18 ± 4.63 | 9.87 ± 5.15 | 0.777 | ||
| RMT | mm | 5.51 ± 2.59 | 5.05 ± 3.16 | 0.479 | ||
| AMT | mm | 10.88 ± 2.83 | 11.17 ± 3.84 | 0.706 |
Note: Data are mean ± standard deviation, n, or n (%).
Abbreviations: AMT, adjacent myometrium thicknesses; CSD, cesarean scar defect; RMT, residual myometrium thickness; SIS, saline infusion sonohysterography.